ES2137655T3 - Purificacion del factor tejido. - Google Patents

Purificacion del factor tejido.

Info

Publication number
ES2137655T3
ES2137655T3 ES96890019T ES96890019T ES2137655T3 ES 2137655 T3 ES2137655 T3 ES 2137655T3 ES 96890019 T ES96890019 T ES 96890019T ES 96890019 T ES96890019 T ES 96890019T ES 2137655 T3 ES2137655 T3 ES 2137655T3
Authority
ES
Spain
Prior art keywords
tissue factor
purification
clear solution
biogenic
reconstitution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96890019T
Other languages
English (en)
Inventor
Hartmut Dr Lang
Berta Dr Moritz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter AG
Original Assignee
Baxter AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter AG filed Critical Baxter AG
Application granted granted Critical
Publication of ES2137655T3 publication Critical patent/ES2137655T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

SE DESCRIBE UNA PREPARACION DE FACTOR DE TEJIDO ACTIVA, QUE PUEDE ESTAR PRESENTE O BIEN COMO SOLUCION CLARA O BIEN EN FORMA LIOFILIZADA PARA LA OBTENCION DE UNA SOLUCION CLARA EN UNA APLICACION DE RECONSTITUCION, QUE - CONTIENE UN FACTOR DE TEJIDO, QUE PROCEDE DE UN MATERIAL DE PARTIDA BIOGENICO Y SE PURIFICA MEDIANTE CROMATOGRAFIA DE AFINIDAD, - CONTIENE FOSFOLIPIDO ALTAMENTE PURIFICADO Y - NO CONTIENE NINGUN ION METALICO PESADO.
ES96890019T 1995-02-15 1996-02-12 Purificacion del factor tejido. Expired - Lifetime ES2137655T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0027595A AT403437B (de) 1995-02-15 1995-02-15 Physiologisch aktive gewebefaktor-präparation

Publications (1)

Publication Number Publication Date
ES2137655T3 true ES2137655T3 (es) 1999-12-16

Family

ID=3486221

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96890019T Expired - Lifetime ES2137655T3 (es) 1995-02-15 1996-02-12 Purificacion del factor tejido.

Country Status (6)

Country Link
EP (1) EP0727434B1 (es)
AT (2) AT403437B (es)
DE (1) DE59602836D1 (es)
ES (1) ES2137655T3 (es)
FI (1) FI960655A7 (es)
NO (1) NO960565L (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7148067B2 (en) * 2004-08-31 2006-12-12 The Board Of Trustees Of The University Of Illinois Thromboplastin reagents
WO2006096345A2 (en) 2005-03-04 2006-09-14 The Board Of Trustees Of The University Of Illinois Coagulation and fibrinolytic cascades modulator
WO2009046194A2 (en) 2007-10-05 2009-04-09 The Board Of Trustees Of The University Of Illinois Fibrin sealant
US20100297257A1 (en) 2007-11-09 2010-11-25 National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs) Anticoagulant antagonist and hemophillia procoagulant

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5314695A (en) * 1990-11-13 1994-05-24 Corvas International, Inc. Tissue factor based prothrombin time reagent
ATE163768T1 (de) * 1991-10-04 1998-03-15 Dade Int Inc Herstellung von prothrombinzeit-reagenzien aus rekombinantem menschlichem gewebefaktor und sythetischen phospholipiden
DE4243729A1 (de) * 1992-12-23 1994-06-30 Behringwerke Ag Verfahren zur Reaktivierung von gereinigten Membranproteinen
DE4407386B4 (de) * 1994-03-05 2009-01-15 Dade Behring Marburg Gmbh Verfahren zur Reaktivierung von gereinigten Membranproteinen durch Einfrieren

Also Published As

Publication number Publication date
FI960655L (fi) 1996-08-16
DE59602836D1 (de) 1999-09-30
AT403437B (de) 1998-02-25
EP0727434A1 (de) 1996-08-21
EP0727434B1 (de) 1999-08-25
NO960565L (no) 1996-08-16
FI960655A0 (fi) 1996-02-14
ATE183752T1 (de) 1999-09-15
FI960655A7 (fi) 1996-08-16
ATA27595A (de) 1997-07-15
NO960565D0 (no) 1996-02-13

Similar Documents

Publication Publication Date Title
BR9713914A (pt) Composto, uso do mesmo, composição farmacêutica, e processo para tratar um paciente sofrendo de um distúrbio que é susceptìvel a tratamento com um agonista da trombopoietina.
BR0008635A (pt) Kit para radiomarcação de proteìnas com ìtrio-90
BR9909110A (pt) Usos de esmilagenina e anzurogenina d, compoisção farmacêutica tendo propriedades intensificadoras da função cognitiva, processo para intensificar a função cognitiva, e, composição para uso do mesmo
BR9713400A (pt) Processos e compostos para inibir liberação de peptìdeo beta-amilóide e/ou sua sìntese.
HK1044543A1 (en) Beta-secretase enzyme compositions and methods
DE69626660D1 (en) 2-alkylpyrrolidine
WO1996020688A3 (en) Triggered pore-forming agents
EP2050750A3 (en) Multicyclic compounds and their use as inhibitors of PARP, VEGFR2 and MLK3 enzymes
ES2194869T3 (es) Composicion adhesiva biologica y uso de la misma.
BR9811599A (pt) Compostos de dipetìdeo que inibem adesão de leucócito mediada por vla-4
TW200504078A (en) Therapeutically active compounds and their use
ATE211135T1 (de) Aminocyclohexylester und ihre anwendung
DE59904569D1 (de) Therapeutikum zur unterdrückung von schnarchgeräuschen
UA70919C2 (uk) Композиція для лікування та запобігання артеріальному тромбозу з використанням інгібітора фактора ха окремо або в комбінації з препаратом, що унеможливлює агрегацію тромбоцитів
CA2253287A1 (en) A process for producing a recombinant polypeptide involving the addition of an inhibitor of metal-dependent proteases or chymotrypsins to the cell culture medium
HK1041824B (zh) 治療系統
AR003176A1 (es) Una composicion farmaceutica para inhibir el crecimiento de cancer
DE69519602D1 (de) Kugelförmige Aktivkohle zur Behandlung von Hämorrhoiden
TR200103125T2 (tr) Otizmin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri.
Hazum et al. Rapid degradation of [3H] leucine-enkephalin by intact neuroblastoma cells
TR199801798T2 (xx) Otizm tedavisi.
AU9067198A (en) Proton pump inhibitor in therapeutic combination with antibacterial substances
DK0934342T3 (da) Præparat indeholdende chitosan
NO960565L (no) Rensning av vevsfaktor
SI1423126T1 (sl) Terapija hiperproliferativnih stanj na telesnih povrsinah

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 727434

Country of ref document: ES